5/9/2022SMEI: Review of Chinese Terminal Drug Markets in 2011 – 2021

5/6/2022Orion Enters into Exclusive Deal with Jemincare for Novel Non-Opioid D...

5/6/2022Drug R&D and Product Registration News Digest May 2022 (1)

5/6/2022Recent Executive Moves

5/4/2022BeiGene/Amgen Granted CN Conditional Approval of BLINCYTO (Blinatumo...

5/4/2022How American Companies are Approaching China's Data, Privacy, and Cybe...

5/2/2022China Continues to Drop Reimbursements via DIP system: PBM

5/2/2022U.S. FDA Snubs Two More China Only-Tested New Drugs from Hutchmed and ...

5/2/2022Merck's MilliporeSigma Invests €100M to Accelerate Single-Use Manufac...

4/29/2022BMS and Chinese Partner LianBio Won FDA Nod for Camzyos to Treat Hea...

4/29/2022NHSA and NHC Issue Notice to Improve National 6th VBP (Insulin Program...

4/29/2022Recent Executive Moves

4/29/2022Financial-related Company News Digest

4/29/2022Adagene-Sanofi's $2.5B Deal Tops March Deals in China (PharmaDJ)

4/28/2022Stevanato Group Acquires Manufacturing Facility in Zhejiang to Suppor...

4/28/2022Sales Expenditures of Listed Chinese Pharma Companies Sharply Up Again...

4/28/2022SMEI Revises Down Chinese Pharma Industry Growth Projection in 2022

4/28/2022Sanofi Reports Q1/2022 Performance, Witnessing 13.4% Growth in China

4/27/2022Xbiome Acquires Clinical-Stage Program Targeting Ulcerative Colitis

4/26/2022AstraZeneca Remain Bullish on Long-term Development in China

4/26/2022NMPA and Chinese Customs Announce Addition of Zhongshan City's Zhongsh...

4/26/2022AstraZeneca Plans Innovation Center for Traditional Chinese Medicines

4/26/2022China Clears Homegrown PD-1 Inhibitors for Solid Tumors (PharmaDJ's Ch...

4/25/2022AstraZeneca Withdraws Suits After SPC Sidesteps Review of "Reverse Pay...

4/22/2022Bayer Seeks Expanded Use of Prostate Cancer Drug Nubeqa in China

4/22/2022Recent Executive Moves

4/21/2022ATUM Accelerates Entry of Bioengineering Solutions into China

4/20/2022Joseph Romanelli Returns to Merck to Lead Human Health International A...

4/20/2022I-Mab Reportedly Weighing Options Including Sale: Bloomberg

4/20/2022PharmaDJ's China Biotech Fundraising Tracker: March 2022

Page:78/367 Total number of articles:10986: [First][<<] [76] [77] [78] [79] [80] [>>] [End]